Infinity Pharmaceuticals (NASDAQ:INFI) Now Covered by StockNews.com

Analysts at StockNews.com assumed coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, Piper Sandler reissued a “neutral” rating on shares of Infinity Pharmaceuticals in a report on Friday, February 24th. Infinity Pharmaceuticals […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Piper Sandler ,Stevenh Holtzman ,Infinity Pharmaceuticals Trading Down ,Level Four Advisory Services ,Connor Clark Lunn Investment Management Ltd ,Mirabella Financial Services ,Infinity Pharmaceuticals Inc ,News Ratings For Infinity Pharmaceuticals Daily ,Virtu Financial ,Infinity Pharmaceuticals ,Infinity Pharmaceuticals Company Profile ,Institutional Investors Weigh In On Infinity Pharmaceuticals ,Get Rating ,Pharmaceuticals Trading Down ,Financial Services ,Four Advisory Services ,Sigma Investments ,Lunn Investment Management ,Infinity Pharmaceuticals Daily ,Nasdaq Infi ,Infi ,Medical ,45665g30 ,Initiated Coverage ,Stocknews Com ,